3M CO
For the period ended Dec 31, 2025. Filed Feb 3, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 3, 2026
MMM$188.63+1.9%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statement of Changes in Equity
| 3M Company shareholders | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| (Dollars in millions, except per share amounts) · Total · Common stock and additional paid-in capital · Retained earnings · Treasury stock · Accumulated other comprehensive income (loss) · Non-controlling interest | |||||||||||
| Balance at December 31, 2022 | $14,770 | $6,700 | $47,950 | $(33,255) | $(6,673) | $48 | |||||
| Net income (loss) | (6,979) | (6,995) | 16 | ||||||||
| Other comprehensive income (loss), net of tax | (105) | (105) | — | ||||||||
| Dividends declared ($6.00 per share, Note 8) | (3,311) | (3,311) | |||||||||
| Stock-based compensation | 265 | 265 | |||||||||
| Reacquired stock | (33) | (33) | |||||||||
| Dividend to noncontrolling interest | (3) | (3) | |||||||||
| Issuances pursuant to stock options and benefit plans | 264 | (165) | 429 | ||||||||
| Balance at December 31, 2023 | 4,868 | 6,965 | 37,479 | (32,859) | (6,778) | 61 | |||||
| Net income | 4,188 | 4,173 | 15 | ||||||||
| Other comprehensive income (loss), net of tax | 462 | 463 | (1) | ||||||||
| Solventum spin-off | (2,167) | (2,751) | 584 | ||||||||
| Dividends declared ($3.61 per share, Note 8) | (1,982) | (1,982) | |||||||||
| Stock-based compensation | 273 | 273 | |||||||||
| Reacquired stock | (1,817) | (1,817) | |||||||||
| Dividend to noncontrolling interest | (23) | (23) | |||||||||
| Issuances pursuant to stock options and benefit plans | 92 | (122) | 214 | ||||||||
| Balance at December 31, 2024 | 3,894 | 7,238 | 36,797 | (34,462) | (5,731) | 52 | |||||
| Net income | 3,262 | 3,250 | 12 | ||||||||
| Other comprehensive income (loss), net of tax | 648 | 651 | (3) | ||||||||
| Solventum spin-off | (3) | (14) | 11 | ||||||||
| Dividends declared ($2.92 per share, Note 8) | (1,562) | (1,562) | |||||||||
| Stock-based compensation | 211 | 211 | |||||||||
| Reacquired stock | (3,249) | (3,249) | |||||||||
| Dividend to noncontrolling interest | (16) | (16) | |||||||||
| Issuances pursuant to stock options and benefit plans | 1,562 | (213) | 1,775 | ||||||||
| Balance at December 31, 2025 | $4,747 | $7,449 | $38,258 | $(35,936) | $(5,069) | $45 | |||||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.